Holger Sueltmann

Title: Holger Sueltmann: Innovator in Prostate Cancer Research

Introduction

Holger Sueltmann is a notable inventor based in Limburgerhof, Germany. He has made significant contributions to the field of cancer research, particularly in the identification of biomarkers for prostate cancer. His work focuses on the genomic regions that can aid in the diagnosis and monitoring of this disease.

Latest Patents

Holger Sueltmann holds a patent related to prostate cancer markers. The invention pertains to the identification and selection of novel genomic regions that are hypermethylated in subjects with prostate cancer compared to those without. This patent encompasses nucleic acids that selectively hybridize to these genomic regions, as well as compositions and kits that include these nucleic acids. Additionally, the invention provides methods for using these nucleic acids to monitor disease regression and the efficacy of therapeutic regimens.

Career Highlights

Holger Sueltmann is associated with the Max Planck Society for the Advancement of Science, where he continues to contribute to groundbreaking research. His work has implications for improving diagnostic methods and treatment strategies for prostate cancer.

Collaborations

He has collaborated with notable colleagues such as Michal Schweiger and Hans Lehrach, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Holger Sueltmann's innovative work in identifying prostate cancer biomarkers represents a significant advancement in cancer research. His contributions are vital for improving diagnostic and therapeutic approaches in the fight against prostate cancer.